We are live on ! Find out more
SEP

Signature Equity Partners Portfolio holdings

AUM $218M
This Fund
S&P 500
This Quarter Est. Return
+17.82%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$218M
AUM Growth
+$31.5M
Cap. Flow
+$10.7M
Cap. Flow %
4.92%
Top 10 Hldgs %
24.17%
Holding
1,727
New
177
Increased
579
Reduced
510
Closed
156

Sector Composition

Rank Sector Weight
1 Technology 17.06%
2 Industrials 6.38%
3 Financials 5.38%
4 Consumer Discretionary 5.23%
5 Communication Services 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADT icon
1576
ADT
ADT
$5.44B
-49
Closed -$322
AL
1577
DELISTED
Air Lease Corp
AL
-14
Closed -$921
ALG icon
1578
Alamo Group
ALG
$2.01B
-6
Closed -$991
AMCR icon
1579
Amcor
AMCR
$21.8B
-14
Closed -$557
GOLD
1580
Gold.com Inc
GOLD
$1.32B
-183
Closed -$7.33K
AREC icon
1581
American Resources Corp
AREC
$286M
-500
Closed -$1.21K
ATKR icon
1582
Atkore
ATKR
$3.16B
-156
Closed -$9.19K
AYI icon
1583
Acuity Brands
AYI
$10.2B
-22
Closed -$6.18K
BEPC icon
1584
Brookfield Renewable
BEPC
$6.13B
-47
Closed -$1.89K
BFAM icon
1585
Bright Horizons
BFAM
$3.62B
-11
Closed -$903
BIDU icon
1586
Baidu
BIDU
$31.6B
-225
Closed -$25.1K
BL icon
1587
BlackLine
BL
$1.82B
-7
Closed -$259
BNTX icon
1588
BioNTech
BNTX
$28.3B
-3
Closed -$267
BRX icon
1589
Brixmor Property Group
BRX
$9.02B
-150
Closed -$4.32K
BTZ icon
1590
BlackRock Credit Allocation Income Trust
BTZ
$948M
-200
Closed -$2.02K
CE icon
1591
Celanese
CE
$4.91B
-97
Closed -$6.38K
CLX icon
1592
Clorox
CLX
$12.6B
-4
Closed -$415
CRBU icon
1593
Caribou Biosciences
CRBU
$177M
-177
Closed -$336
CRSP icon
1594
CRISPR Therapeutics
CRSP
$5.73B
-24
Closed -$1.14K
CSGP icon
1595
CoStar Group
CSGP
$13B
-29
Closed -$1.17K
CSGS
1596
DELISTED
CSG Systems International
CSGS
-10
Closed -$799
CSIQ icon
1597
Canadian Solar
CSIQ
$942M
-31
Closed -$429
CSTL icon
1598
Castle Biosciences
CSTL
$1.04B
-16
Closed -$393
CTRA
1599
DELISTED
Coterra Energy
CTRA
-7
Closed -$255
CTSH icon
1600
Cognizant
CTSH
$28B
-599
Closed -$36.7K

Similar funds

Signature Equity Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Signature Equity Partners held 1,727 positions worth $218M, up 17% from $186M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Signature Equity Partners deployed $10.7M of net new capital in Q2 2026, opening 177 new positions and adding to 579 existing holdings. Its largest new stake was AB Disruptors ETF: 22,901 shares worth $3.39M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was T. Rowe Price Capital Appreciation Equity ETF, an estimated $1.6M trimmed.

  • Signature Equity Partners's largest Q2 2026 buy was AB Disruptors ETF: 22,901 shares worth $3.39M.
  • Signature Equity Partners added most to Apple in Q2 2026, an estimated $1.95M increase.
  • Signature Equity Partners's biggest Q2 2026 reduction was T. Rowe Price Capital Appreciation Equity ETF, cutting an estimated $1.6M.
  • Signature Equity Partners fully exited State Street US Sector Rotation ETF in Q2 2026, selling an estimated $169K.
  • Signature Equity Partners's ten largest holdings make up 24% of its $218M portfolio in Q2 2026.
  • Signature Equity Partners opened 177 new positions and closed 156 in Q2 2026.
  • Signature Equity Partners's portfolio value rose 17% quarter-over-quarter to $218M.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.